Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signaling

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 9, 2014, Pages 1796-1804

  Penzo, Marianna ^a,b   Habiel, David M ^b,c,d   Ramadass, Mahalakshmi ^b,c,d   Kew, Richard R ^b,c   Marcu, Kenneth B ^b,c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b STONY BROOK UNIVERSITY   (United States)

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Cell migration; CXCL12; CXCR4; IKK ; IKK ; NF B

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL MIGRATION; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOBLOTTING; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; POLARIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL; TIME-LAPSE VIDEO MICROSCOPY; UPREGULATION;

CELL MIGRATION; CXCL12; CXCR4; IKKΑ; IKKΒ; NF-ΚB;

ANIMALS; CELL MOVEMENT; CELL NUCLEUS; CHEMOKINE CXCL12; FIBROBLASTS; HUMANS; I-KAPPA B KINASE; MACROPHAGES; MICE; MICE, KNOCKOUT; NF-KAPPA B; RECEPTORS, CXCR4; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; UP-REGULATION;

EID: 84902491261     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.04.011     Document Type: Article

References (65)

1. Miller R.J., Banisadr G., Bhattacharyya B.J. CXCR4 signaling in the regulation of stem cell migration and development. J. Neuroimmunol. 2008, 198:31-38.
2. Kucia M., Jankowski K., Reca R., Wysoczynski M., Bandura L., Allendorf D.J., Zhang J., Ratajczak J., Ratajczak M.Z. CXCR4-SDF-1 signaling, locomotion, chemotaxis and adhesion. J. Mol. Histol. 2004, 35:233-245.
3. Ganju R.K., Brubaker S.A., Meyer J., Dutt P., Yang Y., Qin S., Newman W., Groopman J.E. The α-chemokine, stromal cell-derived factor-1α, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J. Biol. Chem. 1998, 273:23169-23175.
4. Tilton B., Ho L., Oberlin E., Loetscher P., Baleux F., Clark-Lewis I., Thelen M. Signal transduction by Cxc chemokine receptor 4: stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J. Exp. Med. 2000, 192:313-324.
5. Chernock R.D., Cherla R.P., Ganju R.K. SHP2 and cbl participate in α-chemokine receptor CXCR4-mediated signaling pathways. Blood 2001, 97:608-615.
6. Helbig G., Christopherson K.W., Bhat-Nakshatri P., Kumar S., Kishimoto H., Miller K.D., Broxmeyer H.E., Nakshatri H. NF-{kappa} B promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 2003, 278:21631-21638.
7. Neuhaus T., Stier S., Totzke G., Gruenewald E., Fronhoffs S., Sachinidis A., Vetter H., Ko Y.D. Stromal cell-derived factor 1α (SDF-1α) induces gene-expression of early growth response-1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation. Cell Prolif. 2003, 36:75-86.
8. Kukreja P., Abdel-Mageed A.B., Mondal D., Liu K., Agrawal K.C. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Cancer Res. 2005, 65:9891-9898.
9. Palumbo R., Galvez B.G., Pusterla T., De Marchis F., Cossu G., Marcu K.B., Bianchi M.E. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-{kappa}B activation. J. Cell Biol. 2007, 179:33-40.
10. Baldwin A. The NF-kappaB and IkappaB proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
11. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
12. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
13. May M.J., Ghosh S. IkappaB kinases: kinsmen with different crafts. Science 1999, 284:271-273.
14. Yamamoto Y., Gaynor R.B. IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem. Sci. 2004, 29:72-79.
15. Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 2006, 25:6685-6705.
16. Cao Y., Bonizzi G., Seagroves T.N., Greten F.R., Johnson R., Schmidt E.V., Karin M. IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 2001, 107:763-775.
17. Hansberger M.W., Campbell J.A., Danthi P., Arrate P., Pennington K.N., Marcu K.B., Ballard D.W., Dermody T.S. IkappaB kinase subunits alpha and gamma are required for activation of NF-kappaB and induction of apoptosis by mammalian reovirus. J. Virol. 2007, 81:1360-1371.
18. Lawrence T., Bebien M., Liu G.Y., Nizet V., Karin M. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 2005, 434:1138-1143.
19. Li Q., Lu Q., Bottero V., Estepa G., Morrison L., Mercurio F., Verma I.M. Enhanced NF-{kappa}B activation and cellular function in macrophages lacking I{kappa}B kinase 1 (IKK1). PNAS 2005, 102:12425-12430.
20. Liu B., Yang Y., Chernishof V., Loo R.R.O., Jang H., Tahk S., Yang R., Mink S., Shultz D., Bellone C.J., Loo J.A., Shuai K. Proinflammatory stimuli induce IKK[alpha]-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Cell 2007, 129:903-914.
21. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C., Karin M. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001, 293:1495-1499.
22. Xiao G., Harhaj E.W., Sun S.-C. NF-[kappa]B-inducing kinase regulates the processing of NF-[kappa]B2 p100. Mol. Cell 2001, 7:401-409.
23. Yang C.H., Murti A., Pfeffer S.R., Kim J.G., Donner D.B., Pfeffer L.M. Interferon alpha/beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt. J. Biol. Chem. 2001, 276:13756-13761.
24. Saitoh T., Nakayama M., Nakano H., Yagita H., Yamamoto N., Yamaoka S. TWEAK induces NF-{kappa}B2 p100 processing and long lasting NF-{kappa}B activation. J. Biol. Chem. 2003, 278:36005-36012.
25. Yang C.H., Murti A., Pfeffer L.M. Interferon induces NF-{kappa}B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-{kappa}B activation to promote cell survival. J. Biol. Chem. 2005, 280:31530-31536.
26. Basak S., Kim H., Kearns J.D., Tergaonkar V., O'Dea B., Werner S.L., Benedict C.A., Ware C.F., Ghosh G., Verma I.M., Hoffmann A. A Fourth IkappaB protein within the NF-kappaB Signaling Module. Cell 2007, 128:369-381.
27. Ko J., Kim I.S., Jang S.W., Lee Y.H., Shin S.Y., Min D.S., Na D.S. Leukotactin-1/CCL15-induced chemotaxis signaling through CCR1 in HOS cells. FEBS Lett. 2002, 515:159-164.
28. Ko J., Jang S.W., Kim Y.S., Kim I.S., Sung H.J., Kim H.H., Park J.Y., Lee Y.H., Kim J., Na D.S. Human LZIP binds to CCR1 and differentially affects the chemotactic activities of CCR1-dependent chemokines. FASEB J. 2004, 18:890-892.
29. Jang S.-W., Kim Y.S., Kim Y.R., Sung H.J., Ko J. Regulation of human LZIP expression by NF-{kappa}B and its involvement in monocyte cell migration induced by Lkn-1. J. Biol. Chem. 2007, 282:11092-11100.
30. Penzo M., Molteni R., Suda T., Samaniego S., Raucci A., Habiel D.M., Miller F., Jiang H.-p., Li J., Pardi R., Palumbo R., Olivotto E., Kew R.R., Bianchi M.E., Marcu K.B. Inhibitor of NF-{kappa}B kinases {alpha} and {beta} are both essential for high mobility group Box 1-mediated chemotaxis. J. Immunol. 2010, 184:4497-4509.
31. Kew R.R., Penzo M., Habiel D.M., Marcu K.B. The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1. J. Immunol. 2012, 188:2380-2386.
32. Huttunen H.J., Fages C., Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 1999, 274:19919-19924.
33. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D.M., Nawroth P.P. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005, 83:876-886.
34. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 2005, 5:331-342.
35. Tang C.-H., Chuang J.-Y., Fong Y.-C., Maa M.-C., Way T.-D., Hung C.-H. Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-{kappa}B pathways and promotes osteoclastogenesis in human oral cancer cells. Carcinogenesis 2008, 29:1483-1492.
36. Lu D.-Y., Tang C.-H., Yeh W.-L., Wong K.-L., Lin C.-P., Chen Y.-H., Lai C.-H., Chen Y.-F., Leung Y.-M., Fu W.-M. SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia. Eur. J. Pharmacol. 2009, 613:146-154.
37. Chu C.-Y., Cha S.-T., Lin W.-C., Lu P.-H., Tan C.-T., Chang C.-C., Lin B.-R., Jee S.-H., Kuo M.-L. Stromal cell-derived factor-1{alpha} (SDF-1{alpha}/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-{kappa}B/interleukin-6 pathway. Carcinogenesis 2009, 30:205-213.
38. Huang CY L.C., Chen M.Y., Yang W.H., Chen Y.H., Chang C.H., Hsu H.C., Fong Y.C., Tang C.H. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways. J. Cell. Physiol. 2009, 221:204-212.
39. Diamond P., Labrinidis A., Martin S.K., Farrugia A.N., Gronthos S., To L.B., Fujii N., O'Loughlin P.D., Evdokiou A., Zannettino A.C.W. Targeted Disruption of the CXCL12/CXCR4 Axis Inhibits Osteolysis in a Murine Model of Myeloma-Associated Bone Loss. J. Bone Miner. Res. 2009, 24:1150-1161.
40. Massa P.E., Li X., Hanidu A., Siamas J., Pariali M., Pareja J., Savitt A.G., Catron K.M., Li J., Marcu K.B. Gene expression profiling in conjunction with physiological rescues of IKKalpha null cells with wild type or mutant IKKalpha reveals distinct classes of IKKalpha/NF-kappaB-dependent genes. J. Biol. Chem. 2005, 280:14057-14069.
41. Penzo M., Massa P.E., Olivotto E., Bianchi F., Borzi R.M., Hanidu A., Li X., Li J., Marcu K.B. Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1. J. Cell. Physiol. 2009, 218:215-227.
42. Zigmond S.H., Hirsch J.G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J. Exp. Med. 1973, 137:387-410.
43. Zantl R., Rädler U., Horn E. Chemotaxis in mu channels. Imaging Microsc. 2006, 8:30-32.
44. Amara A., Gall S.L., Schwartz O., Salamero J., Montes M., Loetscher P., Baggiolini M., Virelizier J.-L., Arenzana-Seisdedos F. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 1997, 186:139-146.
45. Orsini M.J., Parent J.L., Mundell S.J., Benovic J.L., Marchese A. Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization. J. Biol. Chem. 1999, 274:31076-31086.
46. Dejardin E., Droin N.M., Delhase M., Haas E., Ca Y., Makris C., Karin M., Ware C.F., Green D.R. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 2002, 17:525-535.
47. Qing G., Xiao G. Essential Role of I{kappa}B Kinase {alpha} in the Constitutive Processing of NF-{kappa}B2 p100. J. Biol. Chem. 2005, 280:9765-9768.
48. Horwitz R., Webb D. Cell migration. Curr. Biol. 2003, 13:R756-R759.
49. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., Horwitz A.R. Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709.
50. Imitola J., Raddassi K., Park K.I., Mueller F.-J., Nieto M., Teng Y.D., Frenkel D., Li J., Sidman R.L., Walsh C.A., Snyder E.Y., Khoury S.J. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. 2004, 101:18117-18122.
51. Palumbo R., Bianchi M.E. High mobility group box 1 protein, a cue for stem cell recruitment. Biochem. Pharmacol. 2004, 68:1165-1170.
52. Guo Y., Hangoc G., Bian H., Pelus L.M., Broxmeyer H.E. SDF-1/CXCL12 enhances survival and chemotaxis of murine embronic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells 2005, 23:1324-1332.
53. Galvez B.G., Sampaolesi M., Brunelli S., Covarello D., Gavina M., Rossi B., Costantin G., Torrente Y., Cossu G. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J. Cell Biol. 2006, 174:231-243.
54. Carbajal K.S., Schaumburg C., Strieter R., Kane J., Lane T.E. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc. Natl. Acad. Sci. 2010, 107:11068-11073.
55. Andersson U., Erlandsson-Harris H., Yang H., Tracey K.J. HMGB1 as a DNA-binding cytokine. J. Leukoc. Biol. 2002, 72:1084-1091.
56. Dumitriu I.E., Baruah P., Manfredi A.A., Bianchi M.E., Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol. 2005, 26:381-387.
57. Palumbo R., Sampaolesi M., De Marchis F., Tonlorenzi R., Colombetti S., Mondino A., Cossu G., Bianchi M.E. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 2004, 164:441-449.
58. Schiraldi M., Raucci A., Munoz L.M., Livoti E., Celona B., Venereau E., Apuzzo T., De Marchis F., Pedotti M., Bachi A., Thelen M., Varani L., Mellado M., Proudfoot A., Bianchi M.E., Uguccioni M. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J. Exp. Med. 2012, 209:551-563.
59. Ivanov S., Dragoi A.-M., Wang X., Dallacosta C., Louten J., Musco G., Sitia G., Yap G.S., Wan Y., Biron C.A., Bianchi M.E., Wang H., Chu W.-M. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007, 110:1970-1981.
60. Sha Y., Zmijewski J., Xu Z., Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 2008, 180:2531-2537.
61. Urbonaviciute V., Furnrohr B.G., Meister S., Munoz L., Heyder P., De Marchis F., Bianchi M.E., Kirschning C., Wagner H., Manfredi A.A., Kalden J.R., Schett G., Rovere-Querini P., Herrmann M., Voll R.E. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 2008, 205:3007-3018.
62. Hreggvidsdottir H.S., Ostberg T., Wahamaa H., Schierbeck H., Aveberger A.-C., Klevenvall L., Palmblad K., Ottosson L., Andersson U., Harris H.E. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J. Leukoc. Biol. 2009, 86:655-662.
63. Hreggvidsdóttir H.S., Lundberg A.M., Aveberger A.C., Klevenvall L., Andersson U., Harris H.E. HMGB1-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Mol. Med. 2012, 18:224-230.
64. Campana L., Bosurgi L., Bianchi M.E., Manfredi A.A., Rovere-Querini P. Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J. Leukoc. Biol. 2009, 86:609-615.
65. Bonizzi G., Bebien M., Otero D.C., Johnson-Vroom K.E., Cao Y., Vu D., Jegga A.G., Aronow B.J., Ghosh G., Rickert R.C., Karin M. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J. 2004, 23:4202-4210.